SAN FRANCISCO, Dec 24 (Reuters) - It was a Thursday before dawn in Silicon Valley when Intel CEO Lip-Bu Tan found himself under attack by the president of the United States. “The CEO of INTEL is ...
LAS VEGAS, Dec. 16, 2025 /CNW/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing cell-based therapies for diabetes and ...
However, historically, a major challenge in deploying these cells has been the immune system's rejection of implanted foreign material, often necessitating lifelong immunosuppressive drugs that carry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback